Chemokine receptor 2 blockade prevents asthma in a cynomolgus monkey model

Journal of Pharmacology and Experimental Therapeutics

Volumn 324, Issue 2, 2008, Pages 769-775

  Mellado, Mario ^a   De Ana, Ana Martín ^a   Gómez, Lucio ^a   Martínez A , Carlos ^a   Rodríguez Frade, José Miguel ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CHEMOKINE RECEPTOR 2; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; ASTHMA; CALCIUM MOBILIZATION; CELL INFILTRATION; CHEMOTAXIS; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; INFLAMMATION; LUNG FUNCTION; LUNG LAVAGE; LUNG RESISTANCE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

EID: 38749112167     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.128538     Document Type: Article

References (39)

1. Bousquet J, Jeffery PK, Busse WW, Johnson M, and Vignola AM (1999) Asthma; From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161:1720-1745.
2. Bradley BL, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani AM, Schwartz LB, Durham SR, Jeffery PK, and Kay AB (1991) Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 88:661-674.
3. Breedveld F (2000) Therapeutic monoclonal antibodies. Lancet 355:735-740.
4. -/- mice: the role of mast cells. J Immunol 163:2160-2167.
5. Carroll NG, Mutavdzic S, and James AL (2002) Distribution and degranulation of airway mast cell in normal and asthmatic subjects. Eur Respir J 19:879-885.
6. Chvatchko Y, Proudfoot AE, Buser R, Juillard P, Alouani S, Kosco-Vilbois M, Coyle AJ, Nibbs RJ, Graham G, Offord RE, et al. (2003) Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3. J Immunol 171:5498-5506.
7. Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig M, Barnes N, Robinson D, and Kay A (2003) Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 112:1029-1036.
8. Frade JM, Mellado M, del Real G, Gutierrez-Ramos JC, Lind P, and Martinez AC (1997) Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. J Immunol 159:5576-5584.
9. Glennie MJ and Johnson PW (2000) Clinical trials of antibody therapy. Immunol Today 121:403-410.
10. Gonzalo JA, Lloyd CM, Wen D, Albar JP, Wells TN, Proudfoot A, Martinez-A C, Dorf M, Bjerke T, Coyle AJ, et al. (1998) The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway responsiveness. J Exp Med 188:157-167.
11. Gonzalo JA, Pan Y, Lloyd CM, Jia GQ, Yu G, Dussault B, Powers CA, Proudfoot AE, Coyle AJ, Gearing D, et al. (1999) Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J Immunol 163:403-411.
12. Gundel RH, Gerritsen ME, Gleich GJ, and Wegner CD (1990) Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates. J Appl Physiol 68:779-786.
13. Gutierrez-Ramos JC, Lloyd C, Kapsenberg ML, Gonzalo JA, and Coyle AJ (2000) Non-redundant functional groups of chemokines operate in a coordinate manner during the inflammatory response in the lung. Immunol Rev 177:31-42.
14. Hart T, Blackburn M, Brigham-Burke M, Dede K, Al-Mahdi N, Zia-Amirhosseini P, and Cook R (2002) Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma. Clin Exp Immunol 130:93-100.
15. Huang D, Wang J, Kivisakk P, Rollins BJ, and Ransohoff RM (2001) Absence of monocyte chemoattractant protein 1 in mice leads to decreases local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 193:713-725.
16. Humbles AA, Lu B, Friend DS, Okinaga S, Lora J, Al-Garawi A, Martin TR, Gerard NP, and Gerard C (2002) The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci U S A 99:1479-1484.
17. Kawasaki S, Takizawa H, Yoneyama H, Nakayama T, Fujisawa R, Izumizaki M, Imai T, Yoshie O, Homma I, Yamamoto K, et al. (2001) Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J Immunol 166:2055-2062.
18. Kay AB (2005) The role of eosinophils in the pathogenesis of asthma. Trends Mol Med 11:148-152.
19. Kim Y, Sung SJ, Kuziel WA, Feldman S, Fu SM, and Rose CE Jr (2001) Enhanced airway Th2 response after challenge in mice deficient in CC chemokine receptor-2 (CCR2). J Immunol 166:5183-5192.
20. Li L, Das AM, Torphy TJ, and Griswold DE (2002) What's in the pipeline? Prospects for monoclonal antibodies (mAbs) as therapies for lung diseases. Pulm Pharmacol Ther 15:409-416.
21. Lloyd CM, Delaney T, Nguyen T, Tian J, Martinez-A C, Coyle AJ, and Gutierrez-Ramos JC (2000) CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/ monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 191:265-274.
22. Lukacs NW, Miller AL, and Hogaboam CM (2003) Chemokine receptors in asthma: searching for the correct immune targets. J Immunol 171:11-15.
23. Marone G, Triggiani M, and de Paulis A (2005) Mast cells and basophils: friends as well as foes in bronchial asthma? Trends Immunol 26:25-33.
24. Mauser PJ, Pitman AM, Fernandez X, Foran SK, Adams GK, Kreutner W, Egan RW, and Chapman RW (1995) Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care 152:467-472.
25. Munitz A, Bachelet I, and Levi-Schaffer F (2006) Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J Allergy Clin Immunol 118:1082-1089.
26. Murray LA, Syed F, Li L, Griswold DE, and Das AM (2006) Role of chemokines in severe asthma. Curr Drug Targets 7:579-588.
27. Palmqvist C, Wardlaw AJ, and Bradding P (2007) Chemokines and their receptors as potential targets for the treatment of asthma. Br J Pharmacol 151:725-736.
28. Pascual RM and Peters SP (2005) Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J Allergy Clin Immunol 116:477-486.
29. Pease JE (2006) Asthma, allergy and chemokines. Curr Drug Targets 7:3-12.
30. Rothenberg ME, MacLean JA, Pearlman E, Luster AD, and Leder P (1997) Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 185:785-790.
31. Torphy T, Li L, and Griswold DE (2001) Monoclonal antibodies as a strategy for pulmonary diseases. Curr Op Pharmacol 1:265-271.
32. Turner CR, Andresen CJ, Smith WB, and Watson JW (1994) Effects of rolipram on responses to acute and chronic antigen exposure in monkeys. Am J Respir Crit Care 149:1153-1159.
33. Turner CR, Andresen CJ, Smith WB, and Watson JW (1996) Characterization of a primate model of asthma using anti-allergy/anti-asthma agents. Inflamm Res 45:239-245.
34. Ulbrich H, Eriksson EE, and Lindbom L (2003) Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol Sci 24:640-647.
35. Umetsu DT and DeKruyff RH (2006) The regulation of allergy and asthma. Immunol Rev 212:238-255.
36. Umetsu DT, Akbari O, and Dekruyff RH (2003) Regulatory T cells control the development of allergic disease and asthma. J Allergy Clin Immunol 112:480-487.
37. Wegmann M, Göggel R, Sel S, Sel S, Erb KJ, Kalkbrenner F, Renz H, and Garn H (2007) Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma. Am J Respir Cell Mol Biol 36:61-67.
38. William BV, Swaminathan S, Blevins R, Bonini JA, O'Dowd BF, George SR, Weinshank RL, Smith KE, and Bailey WJ (2001) Patent status of the therapeutically important G-protein-coupled receptors. Expert Opin Ther Patents 11:1861-1887.
39. Zou J, Young S, Zhu F, Gheyas F, Skeans S, Wan Y, Wang L, Ding W, Billah M, McClanahan T, et al. (2002) Microarray profile of differentially expressed genes in a monkey model of allergic asthma. Genome Biol 3:0020.1-0020.13.